glp-1 drug least chemical modification structures of receptor antagonists. Representative GLP-1-based therapies for type 2
Description
According to the American Heart Association (AHA) guidelines, direct vasodilators such as hydralazine and minoxidil may be considered in patients with refractory hypertension when other agents fail to achieve adequate control
( Epub 20190325 )
Ripa, R
They were randomized to receive either PIO (in a daily dose of 15 mg) or placebo for 24 weeks, followed by a 24-week PIO extension for those who had completed the main study
